Oxford Square Capital Corp. (OXSQ) — 22% yield masks NAV erosion as half of distributions come from returned capital. Oxford Square’s CLO equity yields compressed from 9.7% to 8.6% in one quarter due ...
Oxford Square Capital Corp. (NASDAQ:OXSQ) carries a yield around 22%, but that number rests on two income streams, one of which is visibly cracking. Understanding what drives that yield, and what ...
The merger leaves unknown the fate of the 650-seat O'Reilly Theater, built for the Public in 1999. In the biggest shakeup on the local theater scene in decades, Pittsburgh’s two largest theater ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The new organization will launch ...
The leadership of Pittsburgh Public Theater and Pittsburgh CLO announced Wednesday that the boards of both companies have voted to merge into a new cultural institution. “This theater will be a ...
PITTSBURGH — The Pittsburgh CLO and Pittsburgh Public Theater are moving towards combining. In August of last year, the CLO, Public Theater and City Theatre announced that they were looking to ...
Pittsburgh CLO and Pittsburgh Public Theater announced they will vote on consolidating their organizations. A letter emailed to supporters on Monday stated the consolidation is “not a merger” but ...
Downtown's O'Reilly Theater is home to Pittsburgh Public Theater. Beset by financial troubles, the boards of Pittsburgh Public Theater and the Pittsburgh CLO are set to vote this month on whether to ...
It's no secret that CLO equity funds have had a horrendous time lately. Distributions have been cut, NAVs have deteriorated, and share prices have fallen sharply across much of the sector. And the ...
Northern Trust Expands CLO Middle Office Offering for Institutional Credit Managers and Asset Owners
Enhancement adds compliance and waterfall support to existing loan closing, treasury, and real-time data services. Northern Trust (Nasdaq: NTRS) today announced an expansion of its existing ...
A closely watched clinical trial in Britain that screened blood for early detection of cancer did not show a reduction in diagnoses at later stages of the disease. By Rebecca Robbins and Gina Kolata A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results